Drug Type Small molecule drug |
Synonyms- |
Target |
Action antagonists |
Mechanism AVPR1A antagonists(Vasopressin V1a receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H23Cl2N3O |
InChIKeyKFYLIVATYVZBDM-UHFFFAOYSA-N |
CAS Registry1622294-25-0 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Anxiety Disorders | Preclinical | United States | 18 Sep 2014 | |
| Depressive Disorder | Preclinical | United States | 18 Sep 2014 | |
| Stress Disorders, Post-Traumatic | Preclinical | United States | 18 Sep 2014 |





